Acute lung infection model with Pseudomonas aeruginosa

Pulmonary infections are one of the leading cause of death in the world. Our line of research is to determine under what conditions bacteriophages could be used to treat pulmonary infections due to bacteria. For this we develop models that allow us to understand the various aspects of the therapeutic application of bacteriophages to the lungs.
Patients with cystic fibrosis are among those particularly vulnerable to bacterial infections, and the bacterium Pseudomonas aeruginosa is the bacterium that is most often encountered in these patients.
We isolated bacteriophage specific P. aeruginosa, and we have successfully demonstrated their effectiveness in one of our models.


This work receives support from Vaincre La Mucoviscidose